stockrow
Friday 6 November 2026
Export RVPH’s income statement to Excel — free account
Reviva Pharmaceuticals Holdings, Inc.
RVPH Healthcare Biotechnology
- EPS
- +92.1%
- Free cash flow
- +57.8%
Quarter to June 2026, against a year earlier
0.37
0.03
+8.82%
Follow RVPH
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (176.60%) | (256.20%) | (419.97%) | 837.84% |
+8 more TTM periods Free account |
|
| (79.46%) | (108.55%) | (126.42%) | (207.23%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(85.63%) | (95.34%) | (253.77%) | (602.91%) | |
Free Cash Flow per Share |
(1.31) | (2.88) | (6.78) | (7.68) | |
Free Cash Flow |
(17.30) | (20.20) | (24.59) | (27.90) | |
| Other line items | |||||
Cash ROIC |
(49.30%) | (50.97%) | (106.53%) | (157.32%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(2,042.17) | (1,992.21) | (1,507.46) | (967.32) | |
Operating CF/Net income |
1.33 | 1.21 | 1.24 | 1.23 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.31) | (2.88) | (6.78) | (7.68) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026